tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market

Aclaris Therapeutics (ACRS) Income Statement

Compare
874 Followers

Aclaris Therapeutics Income Statement

Last quarter (Q3 2025), Aclaris Therapeutics's total revenue was $3.30M, a decrease of -24.09% from the same quarter last year. In Q3, Aclaris Therapeutics's net income was $-14.61M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.72M$ 31.25M$ 29.75M$ 6.76M$ 6.48M
Gross Profit
$ 15.93M$ 13.17M$ 17.79M$ 2.05M$ 1.35M
Operating Expenses
$ 157.86M$ 110.53M$ 107.65M$ 91.77M$ 52.26M
Depreciation and Amortization
$ 807.00K$ 863.00K$ 797.00K$ 923.00K$ 1.32M
EBITDA
$ -51.72M$ -115.45M$ -84.36M$ -64.46M$ -47.20M
Operating Income
$ -141.93M$ -97.36M$ -89.85M$ -89.72M$ -50.91M
Other Income/Expenses
$ 9.87M$ 8.51M$ 2.95M$ -1.14M$ -424.00K
Pretax Income
$ -132.06M$ -88.85M$ -86.91M$ -90.86M$ -51.34M
Net Income
$ -132.06M$ -88.48M$ -86.91M$ -90.86M$ -51.02M
Per Share Metrics
Basic EPS
$ -1.71$ -1.27$ -1.33$ -1.60$ -1.20
Diluted EPS
$ -1.71$ -1.27$ -1.33$ -1.60$ -1.20
Weighted Average Shares Outstanding
77.30M 69.81M 65.21M 56.73M 42.54M
Weighted Average Shares Outstanding (Diluted)
77.30M 69.81M 65.21M 56.73M 42.54M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History